As of 31 Dec 2025, 2 institutional investors reported holding 32,464 shares of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 32,464 | $11,481 | +$687 | $0.32 | 2 |
| 2025 Q3 | 30,000 | $23,550 | +$23,550 | $0.78 | 1 |
| 2020 Q4 | 0 | $0 | -$35,131,000 | $0.32 | 0 |
| 2020 Q3 | 3,282,306 | $35,395,000 | +$1,449,504 | $10.75 | 12 |
| 2020 Q2 | 3,123,407 | $33,528,000 | -$24,757,282 | $10.75 | 16 |
| 2020 Q1 | 5,456,495 | $57,395,000 | +$11,148,830 | $10.52 | 24 |
| 2019 Q4 | 4,400,789 | $46,051,000 | +$5,550,815 | $10.47 | 23 |
| 2019 Q3 | 3,828,712 | $39,629,000 | -$1,301,970 | $10.35 | 21 |
| 2019 Q2 | 3,846,145 | $39,529,000 | +$5,078,502 | $10.26 | 20 |
| 2019 Q1 | 3,413,846 | $34,401,000 | +$14,831,097 | $10.07 | 20 |
| 2018 Q4 | 1,934,532 | $19,037,000 | +$19,037,000 | $9.84 | 13 |